10 Year Financial Data of BioScrip, Inc. (BIOS)

16.25 (1y: +115%)

Market Cap	1.08 B	P/E(ttm)	15.20
Enterprise Value	1.33 B	P/B	3.20

BIOS- NAS (USA)
BioScrip, Inc.

Currently 1/5

Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$16.25

2 Severe Warning Signs 4 Medium Warning Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	-3.2	-20.4	-55.2
EBITDA Growth (%)	0	0	-53.5
Free Cash Flow Growth (%)	0	0	0
Book Value Growth (%)	-2.2	15.9	29.9

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	26.01	27.77	31.45	30.89	31.12	36.49	33.46	32.53	32.97	11.78	12.48	2.81	2.80	3.01	3.18	3.49
EBITDA per Share	0.93	0.76	0.17	-0.14	0.41	-2.01	0.52	0.56	0.97	0.46	0.40	0.12	0.10	0.12	0.12	0.06
Free Cashflow per Share	0.59	0.10	-0.34	-0.95	0.48	-0.42	0.43	-0.65	0.32	0.28	-0.02	0.02	0.30	0.03	-0.06	-0.29
Earnings per Share ($)	0.40	0.31	-0.70	-1.03	0.09	-1.93	1.36	-1.37	0.14	1.15	1.08	-0.05	1.29	-0.20	0.13	-0.14
Book Value per Share	4.74	5.10	5.74	4.34	4.32	2.49	3.92	3.97	3.90	5.22	5.04	3.88	5.29	5.01	5.16	5.04
Month End Stock Price	7.03	6.36	7.54	3.57	7.73	2.22	8.36	5.23	5.46	10.77	12.71	6.79	7.43	9.11	10.77	12.71
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	8.50	6.10	-12.20	-23.70	2.00	-77.50	34.70	-34.60	3.70	22.10	-11.20	-5.20	97.20	-16.40	9.60	-11.20
Return on Assets %	5.30	3.80	-8.30	-12.50	1.10	-30.00	18.80	-10.40	1.20	10.10	-4.80	-1.60	42.40	-7.20	4.40	-4.80
Return on Capital - Joel Greenblatt %	121	53.20	-35.30	-16.20	9.30	-67.40	11.30	10.20	22.40	14.80	-3.20	9.60	13.20	17.20	14.00	-3.20
Debt to Equity	0.00	0.06	0.04	0.33	0.20	0.53	0.21	1.53	1.36	0.77	0.88	1.36	0.87	0.80	0.77	0.88

Gross Margin %	11.60	10.80	10.80	10.40	11.40	10.10	11.90	15.90	17.20	33.90	31.80	34.40	34.00	34.00	33.40	31.80
Operating Margin %	2.70	1.90	-2.70	-1.40	0.70	-6.00	1.20	1.00	2.10	2.00	-0.50	2.60	1.80	2.00	1.70	-0.50
Net Margin %	1.60	1.10	-2.20	-3.30	0.30	-5.30	4.10	-4.20	0.40	9.80	-4.10	-1.70	46.00	-6.80	4.00	-4.10

Days Sales Outstanding	37.70	37.90	40.40	42.80	39.30	41.30	41.50	43.20	45.30	71.10	72.30	142	85.50	75.90	65.00	72.30
Days Inventory	6.00	7.70	9.90	11.80	11.60	13.10	16.00	17.60	13.80	28.40	15.30	12.30	18.80	29.60	25.70	15.30
Inventory Turnover	60.80	47.30	37.00	30.90	31.60	27.90	22.90	20.70	26.50	12.90	6.00	7.40	4.80	3.10	3.50	6.00

Debt to Revenue	0.00	0.01	0.01	0.05	0.03	0.04	0.03	0.19	0.16	0.34	1.27	1.87	1.65	1.33	1.25	1.27
COGS to Revenue	0.88	0.89	0.89	0.90	0.89	0.90	0.88	0.84	0.83	0.66	0.68	0.66	0.66	0.66	0.67	0.68
Inventory to Revenue	0.02	0.02	0.02	0.03	0.03	0.03	0.04	0.04	0.03	0.05	0.12	0.09	0.14	0.22	0.19	0.12
Interest Exp. to Revenue %	-0.14	-0.13	-0.04	-0.26	-0.27	-0.19	-0.14	-1.69	-1.56	-3.93	-3.25	-4.22	-4.36	-3.81	-3.52	-3.25

Asset Turnover	3.44	3.38	3.72	3.77	4.04	5.68	4.63	2.47	2.69	1.03	0.30	0.23	0.23	0.26	0.28	0.30
Buyback Ratio	-6.80	-12.50	7.40	--	-56.30	0.60	-5.60	6.00	--	--	--	--	--	--	--	--
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	589	631	1,073	1,152	1,198	1,402	1,330	1,639	1,818	663	706	156	156	170	181	199
Cost of Goods Sold	520	562	957	1,033	1,061	1,260	1,172	1,378	1,506	438	471	102	103	112	120	136
Gross Profit	68.52	68.16	116	120	137	142	158	260	312	225	235	53.52	53.04	58.00	60.39	63.24

Selling, General, &Admin. Expense	50.63	52.84	109	129	125	130	134	211	237	184	193	48.13	44.69	46.77	49.09	52.79
Earnings Before DDA	21.11	17.32	5.88	-5.39	15.94	-77.12	20.50	28.12	53.38	25.76	22.66	6.85	5.79	6.61	6.66	3.61

Depreciation, Depletion and Amortization	5.08	5.02	35.08	10.85	7.09	6.39	5.03	12.33	15.88	12.47	14.20	2.81	2.93	3.22	3.51	4.54

Operating Income	16.03	12.29	-29.20	-16.24	8.85	-83.52	15.47	15.79	37.50	13.29	8.46	4.04	2.86	3.39	3.15	-0.93
Interest Income/Expense	-0.81	-0.81	-0.39	-3.02	-3.27	-2.71	-1.92	-27.65	-28.31	-26.07	-26.13	-6.57	-6.79	-6.50	-6.36	-6.48
Net Income	9.13	7.03	-23.85	-38.29	3.32	-74.03	54.10	-69.14	7.87	64.71	59.28	-2.70	71.77	-11.54	7.18	-8.13

Earnings per Share ($)	0.40	0.31	-0.70	-1.03	0.09	-1.93	1.36	-1.37	0.14	1.15	1.08	-0.05	1.29	-0.20	0.13	-0.14
Total Shares Outstanding	22.64	22.70	34.13	37.30	38.49	38.42	39.74	50.37	55.15	56.24	57.05	55.31	55.75	56.64	56.90	57.05
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	9.43	2.96	1.52	--	--	--	--	--	--	62.10	--	--	138	67.18	62.10	--
Accounts Receivable	60.86	65.44	119	135	129	159	151	194	225	129	158	242	146	142	129	158
Inventory	8.55	11.90	25.87	33.47	33.60	45.23	51.26	66.51	56.75	34.03	22.82	13.78	21.24	36.60	34.03	22.82
Other Current Assets	2.16	4.91	13.28	2.09	1.43	2.77	16.91	16.70	10.31	10.19	9.08	38.61	5.72	8.87	10.19	9.08
Total Current Assets	81.00	85.20	159	171	164	207	219	277	292	235	190	295	312	255	235	190

Property, Plant and Equipment	5.25	4.30	9.23	10.41	11.74	14.75	15.45	23.92	29.44	23.72	27.77	26.23	20.86	21.12	23.72	27.77
Intangible Assets	76.64	92.46	119	124	121	24.50	24.50	354	349	368	434	331	330	368	368	434
Other Long Term Assets	8.30	4.51	0.94	0.68	0.48	1.07	27.99	8.90	5.82	14.97	14.32	22.11	11.76	12.94	14.97	14.32
Total Assets	171	186	289	305	297	247	287	664	677	642	666	674	675	657	642	666

Accounts Payable	24.97	32.58	51.42	60.95	71.28	86.51	97.81	145	155	107	105	154	108	130	107	105
Current Portion of Long-Term Debt	0.40	7.34	7.43	52.90	33.78	50.41	30.39	81.35	66.16	0.95	27.99	64.05	31.23	0.97	0.95	27.99
Other Current Liabilities	38.59	30.88	33.10	19.83	9.73	10.88	0.00	--	--	--	--	--	0.00	--	--	--
Total Current Liabilities	63.95	70.79	91.95	134	115	148	128	227	221	108	133	218	139	131	108	133

Long-Term Debt	0.04	--	--	--	--	--	2.44	225	227	225	225	227	226	225	225	225
Other Long-Term Liabilities	--	--	0.88	9.95	15.83	3.62	0.79	11.98	13.75	15.27	19.72	13.68	14.81	17.22	15.27	19.72
Total Liabilities	63.99	70.79	92.82	144	131	151	131	464	462	349	378	459	380	373	349	378

Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-14.38	-7.35	-31.20	-69.48	-68.59	-143	-88.52	-158	-150	-85.08	-93.21	-152	-80.73	-92.26	-85.08	-93.21
Additional Paid-In Capital	130	131	235	239	244	248	255	368	376	389	391	378	386	386	389	391
Treasury Stock	-8.00	-8.00	-8.00	-8.00	-9.40	-10.29	-10.37	-10.50	-10.46	-10.31	-10.31	-10.46	-10.31	-10.31	-10.31	-10.31
Total Equity	107	116	196	162	166	95.54	156	200	215	293	287	215	295	284	293	287
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	9.13	7.03	-23.85	-38.29	3.32	-74.03	54.10	-69.14	--	64.71	53.64	--	--	--	61.77	-8.13
Depreciation, Depletion and Amortization	5.08	5.02	35.08	10.85	7.09	6.39	5.03	12.33	15.88	12.47	14.20	2.81	2.93	3.22	3.51	4.54
Cash Flow from Others	0.13	-8.76	-17.66	-2.43	13.78	58.89	-36.39	35.39	11.09	-50.29	-56.33	-0.29	16.19	0.45	-63.71	-9.26
Cash Flow from Operations	14.34	3.29	-6.42	-29.86	24.19	-8.75	22.75	-21.42	26.97	26.88	11.51	2.53	19.11	3.67	1.57	-12.85

Investment for Property, Plant & Equipement	-0.96	-1.06	-5.13	-5.44	-5.53	-7.46	-5.74	-11.11	-9.44	-10.99	-13.09	-1.55	-2.14	-2.16	-5.15	-3.66
Cash Flow from Acquisitions	--	-14.26	--	-13.10	--	--	--	--	--	-13.59	-83.88	-2.94	-7.57	-34.18	31.09	-73.23
Cash Flow from Investing	-0.98	-17.08	3.12	-18.41	-5.53	-7.46	-5.74	-109	-9.91	93.88	18.74	-1.74	149	-44.16	-9.27	-76.88

Net Issuance of Stock	-4.45	0.88	1.78	--	0.47	-0.42	2.90	3.99	3.20	--	-0.17	--	-0.17	--	--	--
Net Issuance of Debt	-5.24	6.44	0.09	45.37	-19.13	16.63	-20.02	139	-20.05	-67.10	-38.01	-2.11	-33.93	-31.00	-0.07	26.99
Other Financing	-0.00	-0.00	--	1.38	-0.00	0.00	0.12	-12.58	-0.21	8.44	7.93	1.32	4.35	0.25	2.69	0.64
Cash Flow from Financing	-9.69	7.31	1.87	46.75	-18.66	16.21	-17.01	130	-17.06	-58.66	-30.25	-0.78	-29.75	-30.75	2.62	27.63

Net Change in Cash	3.68	-6.47	-1.44	-1.52	--	--	--	--	--	62.10	--	--	138	-71.24	-5.08	-62.10

Free Cash Flow	13.38	2.24	-11.55	-35.30	18.66	-16.21	17.01	-32.53	17.53	15.90	-1.58	0.98	16.98	1.52	-3.58	-16.50
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

BIOS Quarterly/Annuals Reports

BIOS: 10-Q/A - BioScrip, Inc. (0001014739) (Filer): (10-Q/A) - 2012-11-09
BIOS: 10-Q - BioScrip, Inc. (0001014739) (Filer): (10-Q) - 2012-11-08
BIOS: 10-Q - BioScrip, Inc. (0001014739) (Filer): (10-Q) - 2012-05-10
BIOS: 10-K - BioScrip, Inc. (0001014739) (Filer): (10-K) - 2012-03-14
BIOS: 10-Q - BioScrip, Inc. (0001014739) (Filer): (10-Q) - 2011-11-09

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

BIOS Quarterly/Annuals Reports